Skip to content
MarketScale
‹ Back to IndustriesHealthcare

The Future of Cancer Care and the Power of Patient Voices

What trends today will kick off a new age for oncology practices? Madelyn Trupkin Herzfeld, CEO for Carevive, which is building technologies that improve the cancer patient treatment experience and survival outcomes while lowering costs, shared her thoughts and insights. With the pandemic adding layers of complexity to the already challenging world of cancer…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
The Future of Cancer Care and the Power of Patient Voices

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

What trends today will kick off a new age for oncology practices? Madelyn Trupkin Herzfeld, CEO for Carevive, which is building technologies that improve the cancer patient treatment experience and survival outcomes while lowering costs, shared her thoughts and insights.

With the pandemic adding layers of complexity to the already challenging world of cancer care, Herzfeld said it wasn’t easy for healthcare providers to add new technology solutions during this time.

“What you’ve heard most about is patients fearing coming in for screenings,” Herzfeld said. “So diagnostic testing and new cancer cases certainly haven’t been identified, because patients have said they are going to put the screening off until after the pandemic.”

One trend coming out of the pandemic is virtual consultations, which Herzfeld believes will continue long after COVID-19.

“Virtual care is finding the right use cases in all areas of healthcare, but particularly in cancer care, where it’s possible to do follow up consults virtually,” Herzfeld said. “You won’t see that go away when the pandemic ends.”

Carevive’s solutions focus on patient-reported outcomes, and Herzfeld shared her excitement on the evolution of cancer care in this area and the many improvements to come.

“Making sure that we understand what the patient is experiencing, what their symptoms are and how can we get in front of them to make the best quality of life when patients have advanced cancer,” Herzfeld said. “So that is taking front and center stage with all stakeholders in the cancer care industry.”

One of the things Carevive is doing to help make cancer treatment better is remote patient monitoring.

“Providers need a scalable technology to do remote patient monitoring, which is a positive thing we’re able to provide them,” Herzfeld said. “We’re also able to provide them with the insights from their data that can really help them improve their practice, improve the treatments they select for patients and improve their symptom management practices.”

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Dental practice exits are turning into multi-year projects, not last-year decisions

Dental practice exits are turning into multi-year projects, not last-year decisions

Dental practice exits now take 3–5+ years of prep. Dental Economics says associate-to-buyout timelines often run three to five-plus years. That pushes revenue-cycle controls, buy-sell terms, and tax structure earlier, before a buyer appears.

  • 01A practical benchmark is emerging for succession: bringing in an associate with intent to buy can take a minimum of three years and often more than five, according to Dental Economics.
  • 02If accounts receivable looks “high,” it may be a bookkeeping and posting problem before it is a payer problem, a revenue-cycle diagnostic Group Dentistry Now says shows up frequently at scale.
  • 03Exit planning is now an operating system project: valuation, tax positioning, and transition support belong in the same workstream, because deal structure can lock in or foreclose tax options, per Dental Economics.

Sep 4, 2026

Scan.com’s $220M round makes imaging an API contract for plans and employers

Scan.com’s $220M round makes imaging an API contract for plans and employers

Scan.com closed $220 million in equity and debt. It’s expanding its U.S. imaging network plus API-based scheduling and results delivery. For health plans and employers, imaging is starting to look like a platform procurement and integration decision, not a directory problem.

  • 01If imaging access is bought via an API, the real spec becomes integration depth: two-way scheduling plus results routing into the EMR, according to Business Wire.
  • 02Scan.com’s mix of $90M equity and $130M debt earmarked for M&A and working capital points to a fast-changing imaging provider network, which can help access but demands discipline in contracting and integration testing.
  • 03The same week’s funding news for Elucid ($55M) suggests AI imaging vendors will keep pushing toward FDA-cleared workflow insertions, a different buying path than network-layer platforms.

Sep 4, 2026

MD&M West 2026 exhibitors pitch audit-ready, AI-ready device platforms

MD&M West 2026 exhibitors pitch audit-ready, AI-ready device platforms

MD&M West 2026 exhibitor messaging suggests compliance testing and AI-ready compute are becoming early decisions, not afterthoughts. Medical Economics described 2026 as a period shaped by rapid technological change, regulatory scrutiny and ongoing economic uncertainty. Medical Design & Outsourcing’s MD&M West 2026 preview points to exhibitors highlighting test equipment, contract manufacturing and other launch support services.

  • 01If a device roadmap includes AI features, the critical path shifts toward data and software evidence that regulators can audit, which means earlier lock-in of compute platforms and test plans, pulling verification and validation into supplier selection.
  • 02MD&M West exhibitor messaging suggests verification and validation capacity is becoming a procurement problem, with rentals and lab-ready gear positioned as a way to avoid booking delays and re-tests, according to Medical Design & Outsourcing.
  • 03With imaging and other new procedural and device concepts moving fast, manufacturing leaders should expect more frequent line-change decisions and component qualification work, as GE HealthCare's photon-counting CT CE mark reported by MedTech Dive and MDDI's New Technologies coverage illustrate.

Sep 3, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512